Dinah Murray obituary
Champion of autistic people who explored the attention that they devote to a leading interestDinah Murray, who has died aged 75 of pancreatic cancer, was a key figure in autism studies, and an indefatigable advocate for autistic people for three decades. Her acute insight lay in the importance of attention and interests to an understanding of the condition.On the autistic spectrum herself andfascinated with language and the mind, in 1991 Murray read Uta Frith ’s book Autism: Explaining the Enigma. She had aeureka moment when it spoke of an autistic person ’s attention “going to their leading interest&rdqu...
Source: Guardian Unlimited Science - July 25, 2021 Category: Science Authors: Penny Warren Tags: Autism Society Psychology Science University of London Source Type: news

New Drug Combination Shows Promise for Peritoneal Mesothelioma
Researchers at MD Anderson Cancer Center in Houston have uncovered a new, promising treatment option for patients with peritoneal mesothelioma, potentially filling a gaping void that exists today. The immunotherapy drug combination of Tecentriq and Avastin, known generically as atezolizumab and bevacizumab, respectively, showed unusual efficacy in a recent study of 20 patients with this rare cancer. Although some patients have previously found significant success and extended survival with the cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combination, or HIPEC, those with unresectable disease ha...
Source: Asbestos and Mesothelioma News - July 21, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Immune cells assemble - boosting the effects of chemotherapy in pancreatic cancer
(Queen Mary University of London) A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 9, 2021 Category: International Medicine & Public Health Source Type: news

Molecular imaging improves staging and treatment of pancreatic ductal adenocarcinomas
(Society of Nuclear Medicine and Molecular Imaging) For patients with pancreatic ductal adenocarcinomas (PDAC), molecular imaging can improve staging and clinical management of the disease, according to research published in the June issue of The Journal of Nuclear Medicine. In a retrospective study of PDAC patients, the addition of PET/CT imaging with 68Ga-FAPI led to restaging of disease in more than half of the patients, most notably in those with local recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 7, 2021 Category: Cancer & Oncology Source Type: news

Blood test to spot pancreatic cancer could be available within months
The first blood test for early diagnosis of the hard-to-spot disease, it could be available within months. Pancreatic cancer has the lowest survival rate of the common cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2021 Category: Consumer Health News Source Type: news

Oncotarget: General anesthesia for pancreatic cancer surgery
(Impact Journals LLC) The major finding of this Oncotarget study was perioperative tryptophan depletion and increased taurine synthesis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2021 Category: Cancer & Oncology Source Type: news

MasSpec Pen shows promise in pancreatic cancer surgery
(University of Texas at Austin) A diagnostic tool called the MasSpec Pen has been tested for the first time in pancreatic cancer patients during surgery. The device is shown to accurately identify tissues and surgical margins directly in patients and differentiate healthy and cancerous tissue from banked pancreas samples. At about 15 seconds per analysis, the method is more than 100 times as fast as the current gold standard diagnostic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 5, 2021 Category: Cancer & Oncology Source Type: news

Scientists reveal a new therapeutic vulnerability in pancreatic cancer
(Columbia University Irving Medical Center) Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news

Online symposium addresses issues of cancer research and palliative care
(Leopoldina) Why does pancreatic cancer develop, what new therapies might be effective against metastasis formation, and what is to be considered in palliative care? Members of the German National Academy of Sciences Leopoldina will address these questions at the virtual symposium of Class III Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 1, 2021 Category: Cancer & Oncology Source Type: news

Study identifies biomarker that could help to diagnose pancreatic cancer
(Queen Mary University of London) Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2021 Category: Cancer & Oncology Source Type: news

Oncotarget: Glucocorticoid receptor antagonism promotes apoptosis in solid tumor cells
(Impact Journals LLC) Support recently reported findings of clinical benefit when relacorilant is added to paclitaxel-containing therapy in patients with ovarian and pancreatic cancers and provide a new rationale for combining relacorilant with additional cytotoxic agents. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 28, 2021 Category: Cancer & Oncology Source Type: news

How pancreatic cancer cells dodge drug treatments
(Cold Spring Harbor Laboratory) Pancreatic cancer cells typically rely on a mutant version of the KRAS protein to proliferate. These cancer cells can also survive losing KRAS by activating alternative growth pathways. CSHL scientists discovered a new interaction between mutant KRAS and a protein complex called RSK1/NF1 that may be the source of this adaptive resistance. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 22, 2021 Category: Cancer & Oncology Source Type: news

Pancreatic cancer symptoms: Survivor Olivia Williams shares 'bizarre' symptom to spot
OLIVIA WILLIAMS starred in An Education, The Sixth Sense and Rushmore, yet the award-winning actress's most fulfilling role is that of Pancreatic Cancer UK ambassador. (Source: Daily Express - Health)
Source: Daily Express - Health - June 17, 2021 Category: Consumer Health News Source Type: news

Targeted drug found effective in thwarting pancreatic tumors
(Virginia Commonwealth University) Through a pre-clinical study conducted in his former role at Moffitt Cancer Center and published in Clinical Cancer Research, Said Sebti, Ph.D., associate director for basic research at VCU Massey Cancer Center, identified a novel drug that effectively thwarts pancreatic tumors that are addicted to the cancer-causing mutant KRAS gene. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2021 Category: Cancer & Oncology Source Type: news

Drug commonly used as antidepressant helps fight cancer in mice
A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain ’s “happiness hormone.”A new study by UCLA researchers suggests that those drugs, commonly known as MAOIs, might have another health benefit: helping the immune system attack cancer. Their findings are reported in two papers, which are published in the journals Science Immunology and Nature Communications.“MAOIs had not been linked to the immune system’s response to cancer before,” saidLili Yang, senior author of the study and a m...
Source: UCLA Newsroom: Health Sciences - June 10, 2021 Category: Universities & Medical Training Source Type: news

First AI-based tool for predicting genomic subtypes of pancreatic cancer from histology slides
(Owkin, Inc.) AP-HP Greater Paris University Hospitals and Owkin announced the recent results of their ongoing strategic collaboration at ASCO 2021. Their abstract demonstrates the first AI-based tool for predicting genomic subtypes of pancreatic cancer (PDAC) developed from machine learning applied to histology slides. The tool, a trained and validated AI model, is usable in clinical practice worldwide and opens the possibility of patient molecular stratification in routine care and for clinical trials. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 10, 2021 Category: Cancer & Oncology Source Type: news

Cancer symptoms: What does your poo smell like? Major warning sign of pancreatic cancer
CANCER symptoms must be acted upon as soon as they arise because early intervention can help stem the spread to other areas. The smell of your poo can signal pancreatic cancer - does yours smell like this? (Source: Daily Express - Health)
Source: Daily Express - Health - June 9, 2021 Category: Consumer Health News Source Type: news

Finding the weak points in radiation-resistant pancreatic cancer cells
(The National Institutes for Quantum and Radiological Science and Technology) Pancreatic cancer is one of the deadliest cancer subtypes not just because it is difficult to diagnose early, but because it is inherently resistant to chemotherapy and radiotherapy. In a recent study, scientists from Japan investigated the relationship that exists between the radiation resistance of pancreatic cancer cells, the natural cell cycle, and a cellular mechanism called autophagy, or " self-digestion. " Their results pave the way for novel radiosensitizers and improved therapeutic strategies for resistant cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 8, 2021 Category: Cancer & Oncology Source Type: news

Biotech firm Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise
A Houston-based biotechnology firm plans to hire and develop a new discovery platform for its cancer therapeutics after a Series A raise. Stellanova Therapeutics is developing an antibody that targets fiber blast cells, which protect cancer cells against treatment and promote cancer cell growth. The company is initially targeting aggressive forms of cancer, like pancreatic cancer and triple-negative breast cancer, said Dr. Rosa Hwan g, co-founder of Stellanova and a member of the firm's scientific… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 7, 2021 Category: Biotechnology Authors: Chris Mathews Source Type: news

Algorithm provides accurate segmentation of pancreas on CT
Deep-learning algorithms can be used to provide automated and accurate segmentatio...Read more on AuntMinnie.comRelated Reading: PET/MRI, CT predict pancreatic cancer treatment response CT shows manifestations of recreational drug use AI can aid radiologists in detecting pancreatic cancer Virtual biopsy accurately diagnoses pancreatic cysts ASTRO updates guidance on pancreatic cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 7, 2021 Category: Radiology Source Type: news

Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise
A Houston-based biotechnology firm plans to hire and develop a new discovery platform for its cancer therapeutics after a Series A raise. Stellanova Therapeutics is developing an antibody that targets fiber blast cells, which protect cancer cells against treatment and promote cancer cell growth. The company is initially targeting aggressive forms of cancer, like pancreatic cancer and triple-negative breast cancer, said Dr. Rosa Hwan g, co-founder of Stellanova and a member of the firm's scientific… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 6, 2021 Category: Biotechnology Authors: Chris Mathews Source Type: news

Stellanova Therapeutics hiring, advancing clinical pipeline after $15.5M raise
A Houston-based biotechnology firm plans to hire and develop a new discovery platform for its cancer therapeutics after a Series A raise. Stellanova Therapeutics is developing an antibody that targets fiber blast cells, which protect cancer cells against treatment and promote cancer cell growth. The company is initially targeting aggressive forms of cancer, like pancreatic cancer and triple-negative breast cancer, said Dr. Rosa Hwan g, co-founder of Stellanova and a member of the firm's scientific… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 6, 2021 Category: Health Management Authors: Chris Mathews Source Type: news

Machine learning brings an early diagnostic for pancreatic cancer a step closer to reality
(London School of Hygiene& Tropical Medicine) Individuals at higher risk of developing pancreatic cancer could be identified earlier using machine learning (ML) techniques which would result in a greater number of patients surviving the disease, suggests a new study published in PLOS ONE. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 2, 2021 Category: Cancer & Oncology Source Type: news

'Electronic nose' accurately sniffs out hard-to-detect cancers
(University of Pennsylvania School of Medicine) An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95% accuracy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 1, 2021 Category: Cancer & Oncology Source Type: news

Minorities Underrepresented in Pancreatic Cancer Clinical Trials Minorities Underrepresented in Pancreatic Cancer Clinical Trials
Better inclusion of underrepresented minorities in clinical trials is critical to reducing healthcare disparities and improving patient outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 27, 2021 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news

Dartmouth and Dartmouth-Hitchcock Cancer Researchers Discover Cutting-Edge Approach to Fighting a Form of Deadly Cancer
Researchers at Norris Cotton Cancer Center have developed a way to predict chemotherapy response to tailor treatments for pancreatic cancer patients. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - May 25, 2021 Category: Hospital Management Authors: NonPerson Geisel Web Service Acct Tags: News Press Release Research Norris Cotton Cancer Center Source Type: news

Unforeseen links to chronic pancreatitis found in cancer-related signals
(Osaka University) Researchers from Osaka University have demonstrated that two signaling pathways, the PI3K and the Hippo pathways earlier implicated in the development of pancreatic cancer, are responsible for the development and progression of chronic pancreatitis. Experiments in animal models, corroboration by laboratory evidence, and studies of human diseased tissue suggest that targeting pathologically upregulated Connective Tissue Growth Factor (CTGF) may be a useful therapeutic strategy against this disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 25, 2021 Category: Cancer & Oncology Source Type: news

Predicting chemotherapy response and tailoring treatments for pancreatic cancer patients
(Dartmouth-Hitchcock Medical Center) After discovering critical epigenetic elements involved in chemotherapy resistance of pancreatic cancer, researchers from Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center have invented a novel biomarker platform that rapidly assesses these elements as a means to predict chemotherapy response and select pancreatic cancer patients who are most likely to benefit from traditional chemotherapy versus possible alternate epigenetic therapy. This technology introduces the first-ever epigenetic precision medicine approach to pancreatic cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2021 Category: International Medicine & Public Health Source Type: news

Pancreatic cancer: Disease causes bowel obstruction with two accompanying warning signs
PANCREATIC cancer symptoms usually do not emerge until the cancer has progressed. When symptoms do appear, they can be vague and non-specific, such as experiencing an unpleasant smell. (Source: Daily Express - Health)
Source: Daily Express - Health - May 21, 2021 Category: Consumer Health News Source Type: news

Pancreatic cancer: Mechanisms of metastasis
(Medical University of Vienna) A study led by MedUni Vienna sheds light on the mechanisms that lead to extremely aggressive metastasis in a particular type of pancreatic cancer, the basal subtype of ductal adenocarcinoma. The results contribute to a better understanding of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 19, 2021 Category: Cancer & Oncology Source Type: news

Mayo Clinic Minute: When colon cancer spreads to the liver
Colorectal cancer is a leading cancer among men and women around the world. Many colorectal cancers are likely to spread to other organs, with the most common site of metastases being the liver. In this Mayo Clinic Minute, Dr. Sean Cleary, a hepatobiliary and pancreas surgeon at Mayo Clinic explains what this means to patients. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 18, 2021 Category: Databases & Libraries Source Type: news

Pancreatic cancer trials fail to include minorities despite worse outcomes
(Digestive Disease Week) Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for presentation at Digestive Disease Week ® (DDW) 2021. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2021 Category: International Medicine & Public Health Source Type: news

Scientists show how to attack the 'fortress' surrounding pancreatic cancer tumors
(University of New South Wales) Tackling the scar tissue that shields pancreatic tumours from effective drug access is a promising advance in a notoriously hard-to-treat cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 13, 2021 Category: Cancer & Oncology Source Type: news

Gene-Targeted Drug Shows Promise Against a Form of Pancreatic Cancer
TUESDAY, May 11, 2021 -- There may be new hope for patients with a subset of pancreatic cancers tied to certain genetic mutations, a new study finds. The study involving 42 patients found that a " PARP inhibitor " drug called rucaparib (Rubraca), may... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 11, 2021 Category: General Medicine Source Type: news

Gene-Targeted Drug Shows Promise Against a Form of Pancreatic Cancer
Title: Gene-Targeted Drug Shows Promise Against a Form of Pancreatic CancerCategory: Health NewsCreated: 5/11/2021 12:00:00 AMLast Editorial Review: 5/11/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 11, 2021 Category: Cancer & Oncology Source Type: news

PARP inhibitor shrinks tumors in pancreatic cancer patients with mutations
(University of Pennsylvania School of Medicine) More than two-thirds of pancreatic cancer patients harboring genetic mutations saw their tumor stop growing or shrink substantially after being switched from intensive chemotherapy to the PARP inhibitor rucaparib as a maintenance therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 10, 2021 Category: Cancer & Oncology Source Type: news

Turning a pancreatic cancer cell's addiction into a death sentence
(University Health Network) Probing the unique biology of human pancreatic cancer cells in a laboratory has yielded unexpected insights of a weakness that can be used against the cells to kill them. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 7, 2021 Category: International Medicine & Public Health Source Type: news

Can Pancreatic Cancer Be Detected by Blood Test?
Title: Can Pancreatic Cancer Be Detected by Blood Test?Category: Diseases and ConditionsCreated: 5/6/2021 12:00:00 AMLast Editorial Review: 5/6/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 6, 2021 Category: Cancer & Oncology Source Type: news

Stem cell-based vaccine offers a new approach that may protect against pancreatic cancer
(International Society for Stem Cell Research) New research by Joseph Wu (joewu@stanford.edu), Edgar Engelman (edgareng@stanford.edu), and colleagues at Stanford University, US has advanced an old concept to develop a new strategy to train the immune system of mice to recognize cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 6, 2021 Category: Cancer & Oncology Source Type: news

Minna Heeraman had an aggressive cancer. Did the March 2020 treatment shutdown shorten her life?
Minna ’s pancreatic surgery was cancelled as a result of the pandemic. By the time treatments resumed, her tumour was too big for doctors to operateWhen Minna Heeraman ’s friends knew that she was dying, they made a video for her to watch from the hospital bed she had set up in her living room. It was a goodbye video. One after another, her friends spoke to the camera with tears in their eyes. They shared their memories of times spent together. Wine in the garde n on sunny afternoons. Hen dos. Weddings. Christmas meet-ups. “I don’t know what more to say, Minna,” says one friend, choking back s...
Source: Guardian Unlimited Science - May 4, 2021 Category: Science Authors: Sirin Kale Tags: Cancer Society Coronavirus Infectious diseases Medical research Science NHS Health Source Type: news

St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy
Galera Therapeutics' stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company's stock began trading Thursday at $9.34 per share after closing Wednesday at $6.61. (Galera's stock simmered down later, closing Thursday at $8.12 a share and opening Friday morning at $7.89.) Galera (NASDAQ: GRTX) is developing proprietary therapies that have the… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 30, 2021 Category: Health Management Authors: John George Source Type: news

St. Louis-born Galera's stock soars after release of positive study data for its experimental cancer therapy
Galera Therapeutics' stock price jumped 41% Thursday morning after the St. Louis-born biopharmaceutical company provided updated results from early-stage testing of its experimental therapy for advanced pancreatic cancer. The company's stock began trading Thursday at $9.34 per share after closing Wednesday at $6.61. (Galera's stock simmered down later, closing Thursday at $8.12 a share and opening Friday morning at $7.89.) Galera (NASDAQ: GRTX) is developing proprietary therapies that have the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 30, 2021 Category: Biotechnology Authors: John George Source Type: news

Ludwig Cancer Research study shows pancreatic cancer cells reverse to advance malignancy
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has identified a previously unrecognized mechanism by which cancer cells of a relatively benign subtype of pancreatic tumors methodically revert--or " de-differentiate " --to a progenitor, or immature, state of cellular development to spawn highly aggressive tumors that are capable of metastasis to the liver and lymph nodes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 28, 2021 Category: International Medicine & Public Health Source Type: news

Scientists create first-of-its-kind 3D organoid model of the human pancreas
(Beth Israel Deaconess Medical Center) Researchers have successfully created the first three-dimensional (3D) organoid models of the pancreas from human stem cells. This first-of-its-kind organoid model includes both the acinar and ductal structures that play a critical role in the majority of pancreatic cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 28, 2021 Category: Cancer & Oncology Source Type: news

Do Blood Tests Show Pancreatic Cancer?
Title: Do Blood Tests Show Pancreatic Cancer?Category: Diseases and ConditionsCreated: 4/27/2021 12:00:00 AMLast Editorial Review: 4/27/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 27, 2021 Category: Cancer & Oncology Source Type: news

Ian Gibson obituary
Cancer researcher who sought to make the public case for science as a Labour MPIan Gibson, who has died aged 82 of pancreatic cancer, had a considerable reputation as a cancer researcher before seeking a political career in order to try to advance the cause of science in public life. He was elected for the first time in 1997, aged 58, as the Labour MP for Norwich North and spent the ensuing 12 years in an energetic pursuit of this case, while also propounding his strongly held convictions on a wide range of issues about health and education.He was a popular, charismatic man who won the influential chairmanship of the Commo...
Source: Guardian Unlimited Science - April 25, 2021 Category: Science Authors: Julia Langdon Tags: Labour Politics past People in science Medical research Norwich UK news Source Type: news

Margin - Positive Surgery Still Beneficial in Pancreatic Cancer
Survival benefit seen for surgery, even with R1/R2 resection margins compared with chemotherapy alone for stage II pancreatic cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 22, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Surgery, Journal, Source Type: news

Margin-Positive Surgery Still Beneficial in Pancreatic Cancer
THURSDAY, April 22, 2021 -- For patients with stage II pancreatic cancer, attempted surgery with margin-positive resection may offer survival benefit over chemotherapy alone, according to a study published online March 26 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 22, 2021 Category: Pharmaceuticals Source Type: news

Pleural Mesothelioma Patients with 5-Year Survival Still Rare
Although no amount of asbestos exposure is considered safe, lower levels of non-occupational exposure are most often linked to long-term survival for those diagnosed with malignant pleural mesothelioma, according to a recent study. Clinical Lung Cancer published the study that compared characteristics of 43 pleural mesothelioma patients who survived at least five years with the disease to a much larger control group. Several previous mesothelioma studies have estimated that the five-year survival rate is just under 5% for pleural mesothelioma, an aggressive cancer with no definitive cure. It is caused almost exclusiv...
Source: Asbestos and Mesothelioma News - April 22, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Improving survival in pancreatic cancer
(Nagoya University) Nagoya University researchers and colleagues have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient response to therapy and increase their overall survival. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 22, 2021 Category: International Medicine & Public Health Source Type: news